2022 Annual General Meeting
Notice is hereby given that a general meeting of the members of Global Health Limited (Company) will be held on 23 November 2022. Read More Please find here the Proxy form
Notice is hereby given that a general meeting of the members of Global Health Limited (Company) will be held on 23 November 2022. Read More Please find here the Proxy form
Read our latest Investor Presentation here.
CEO’s address by Michael Davies at Global Health Limited Annual General Meeting on 24 November 2021. Read More
Notice is hereby given that a general meeting of the members of Global Health Limited (Company) will be held on 24 November 2021. Read More
Global Health raises A$7.8m via Placement to Accelerate Growth in the Digital Healthcare Sector Highlights: Completes A$7.8 million placement to sophisticated investors and leading institutional investors at $0.555 per share Proceeds from the Placement to support an expanded sales force and...
Australian Healthcare Software provider Global Health Limited (ASX:GLH) (“Global Health” or “Company”) is pleased to announce that Wolper Jewish Hospital (Wolper) has signed for the implementation of Global Health’s MasterCare Patient Administration System (PAS) for hospitals on the first-year...
Global Health Limited Investor Presentation March 2021 Despite the continued external challenges of 2020/2021, Global Health Limited has had a successful first half for FY21. Learn more about Global Health Limited’s three-year growth plan and the need for change in this investor relations...
CEO & Managing Director’s address by Mathew Cherian at Global Health Limited Annual General Meeting on 30 November 2020. Read More
In view of the uncertainty resulting from the COVID-19 environment, Australian Healthcare Software provider, Global Health Ltd (ASX: GLH) (“Global Health” or the “Company”) is pleased to provide a brief Business Update to shareholders and the general market for the quarter ended 30 September 2020.
Global Health Limited Investor Relations Presentation Read the Global Health Limited Investor Relations Presentation here. View the Global Health Limited Wholesale Investor profile here.
Read the FY20 Full Year Results Commentary: FY20 Results View the ASX Announcement here.
Read the Letter to Shareholders here: 2019-10-07 Letter to Shareholders.
Read the media release here: Variation from Preliminary Final Report
Read the June 2019 Annual Report to Shareholders here: June 2019 Annual Report to Shareholders
Global Health’s ROCE of 15%, is remarkably higher than the average reported by similar companies in the Healthcare Services industry. Read more about why Global Health is an attractive investment prospect here.
Global Health most recently traded at A$ 0.150 on the 12th of August, 2019. Early this year, Global Health reported its strategic collaboration with Telstra Health to improve the interoperability of clinical data between its ReferralNet platform, and Telstra Health’s Argus Connect platform....
Global Health has a significantly higher Return on Capital Employed (ROCE) in comparison to similar businesses in the Healthcare Services Industry. Its current ROCE of 15%, is notably higher than the industry average of 9%, indicating that it is utilising its capital more...
Please view the annual report via this link: Annual Report Global Health Limited
Simon Turner, Principal at Rising Star Research suggests taking the ethical approach to investment. Before he ventures into investment options, Simon explores what makes a business “ethical”. This can be a long discussion in itself, but to keep things simple most people like to know that their...